Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38922
Submission : 2023-10-18
Status :
Type : II
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-17
Pay. Date : 2013-07-09
DMF Number : 24521
Submission : 2011-05-20
Status :
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Curia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Solubilizers
Parenteral
Fillers, Diluents & Binders
Thickeners and Stabilizers
Granulation
Controlled & Modified Release
Direct Compression
Topical
Emulsifying Agents
Surfactant & Foaming Agents
Co-Processed Excipients
Film Formers & Plasticizers
API Stability Enhancers
Lubricants & Glidants
Rheology Modifiers
Chewable & Orodispersible Aids
Coating Systems & Additives
Disintegrants & Superdisintegrants
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
62
PharmaCompass offers a list of Bromfenac Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bromfenac Sodium manufacturer or Bromfenac Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bromfenac Sodium manufacturer or Bromfenac Sodium supplier.
PharmaCompass also assists you with knowing the Bromfenac Sodium API Price utilized in the formulation of products. Bromfenac Sodium API Price is not always fixed or binding as the Bromfenac Sodium Price is obtained through a variety of data sources. The Bromfenac Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bromfenac ophthalmic manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bromfenac ophthalmic, including repackagers and relabelers. The FDA regulates Bromfenac ophthalmic manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bromfenac ophthalmic API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bromfenac ophthalmic manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bromfenac ophthalmic supplier is an individual or a company that provides Bromfenac ophthalmic active pharmaceutical ingredient (API) or Bromfenac ophthalmic finished formulations upon request. The Bromfenac ophthalmic suppliers may include Bromfenac ophthalmic API manufacturers, exporters, distributors and traders.
click here to find a list of Bromfenac ophthalmic suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bromfenac ophthalmic DMF (Drug Master File) is a document detailing the whole manufacturing process of Bromfenac ophthalmic active pharmaceutical ingredient (API) in detail. Different forms of Bromfenac ophthalmic DMFs exist exist since differing nations have different regulations, such as Bromfenac ophthalmic USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bromfenac ophthalmic DMF submitted to regulatory agencies in the US is known as a USDMF. Bromfenac ophthalmic USDMF includes data on Bromfenac ophthalmic's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bromfenac ophthalmic USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bromfenac ophthalmic suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Bromfenac ophthalmic Drug Master File in Japan (Bromfenac ophthalmic JDMF) empowers Bromfenac ophthalmic API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Bromfenac ophthalmic JDMF during the approval evaluation for pharmaceutical products. At the time of Bromfenac ophthalmic JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Bromfenac ophthalmic suppliers with JDMF on PharmaCompass.
A Bromfenac ophthalmic written confirmation (Bromfenac ophthalmic WC) is an official document issued by a regulatory agency to a Bromfenac ophthalmic manufacturer, verifying that the manufacturing facility of a Bromfenac ophthalmic active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bromfenac ophthalmic APIs or Bromfenac ophthalmic finished pharmaceutical products to another nation, regulatory agencies frequently require a Bromfenac ophthalmic WC (written confirmation) as part of the regulatory process.
click here to find a list of Bromfenac ophthalmic suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bromfenac ophthalmic as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bromfenac ophthalmic API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bromfenac ophthalmic as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bromfenac ophthalmic and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bromfenac ophthalmic NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bromfenac ophthalmic suppliers with NDC on PharmaCompass.
Bromfenac ophthalmic Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bromfenac ophthalmic GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bromfenac ophthalmic GMP manufacturer or Bromfenac ophthalmic GMP API supplier for your needs.
A Bromfenac ophthalmic CoA (Certificate of Analysis) is a formal document that attests to Bromfenac ophthalmic's compliance with Bromfenac ophthalmic specifications and serves as a tool for batch-level quality control.
Bromfenac ophthalmic CoA mostly includes findings from lab analyses of a specific batch. For each Bromfenac ophthalmic CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bromfenac ophthalmic may be tested according to a variety of international standards, such as European Pharmacopoeia (Bromfenac ophthalmic EP), Bromfenac ophthalmic JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bromfenac ophthalmic USP).
